inflammation research

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 659 natural terpenes and terpenoids can be used for high throughput and high content screening;

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 569 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 415 JAK/STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening;

A unique collection of 210 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of 5293 anti-inflammation compounds effective for high throughput screening and high content screening.

609 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa